Filing Details
- Accession Number:
- 0001104659-21-047486
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-04-07 13:59:46
- Reporting Period:
- 2021-04-06
- Accepted Time:
- 2021-04-07 13:59:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1818844 | Virios Therapeutics Inc. | VIRI | Pharmaceutical Preparations (2834) | 854314201 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1831127 | Scott Gregory Duncan | C/O Virios Therapeutics, Inc. 44 Milton Avenue Alpharetta GA 30009 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-04-06 | 382 | $6.36 | 19,961 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- This purchase was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 25, 2021.
Billionaire Hedge Funds
